[HTML] mdpi.com

[HTML][HTML] Evaluation of anti-SARS-Cov-2 S-RBD IgG antibodies after COVID-19 mRNA BNT162b2 vaccine

B Lo Sasso, RV Giglio, M Vidali, C Scazzone, G Bivona… - Diagnostics, 2021 - mdpi.com
(1) Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD)
antibodies represents a useful tool to estimate the individual protection against Severe …
被引用次数：97 相关文章
[PDF] core.ac.uk

[PDF][PDF] Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine. Diagnostics 2021, 11, 1135

B Lo Sasso, RV Giglio, M Vidali, C Scazzone, G Bivona… - 2021 - core.ac.uk
(1) Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD)
antibodies represents a useful tool to estimate the individual protection against Severe …
[PDF] scienceopen.com

[PDF][PDF] Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine. Diagnostics 2021, 11, 1135

B Lo Sasso, RV Giglio, M Vidali, C Scazzone, G Bivona… - 2021 - scienceopen.com
(1) Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD)
antibodies represents a useful tool to estimate the individual protection against Severe …

Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine.

B Lo Sasso, RV Giglio, M Vidali… - Diagnostics (2075 …, 2021 - search.ebscohost.com
Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD)
antibodies represents a useful tool to estimate the individual protection against Severe …
[PDF] unipa.it

[PDF][PDF] Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine. Diagnostics 2021, 11, 1135

B Lo Sasso, RV Giglio, M Vidali, C Scazzone, G Bivona… - 2021 - iris.unipa.it
(1) Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD)
antibodies represents a useful tool to estimate the individual protection against Severe …
[HTML] nih.gov

[HTML][HTML] Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine

BL Sasso, RV Giglio, M Vidali, C Scazzone, G Bivona… - Diagnostics, 2021 - ncbi.nlm.nih.gov
Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD)
antibodies represents a useful tool to estimate the individual protection against Severe …

Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine

BL Sasso, RV Giglio, M Vidali, C Scazzone, G Bivona… - Diagnostics, 2021 - cir.nii.ac.jp
抄録< jats: p>(1) Background: The evaluation of anti-spike protein receptor-binding domain
(S-RBD) antibodies represents a useful tool to estimate the individual protection against …

Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine

BL Sasso, RV Giglio, M Vidali… - Diagnostics (Basel …, 2021 - pubmed.ncbi.nlm.nih.gov
(1) Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD)
antibodies represents a useful tool to estimate the individual protection against Severe …
[PDF] diagnosticapasteur.it

[PDF][PDF] Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine. Diagnostics 2021, 11, 1135

B Lo Sasso, RV Giglio, M Vidali, C Scazzone, G Bivona… - 2021 - diagnosticapasteur.it
(1) Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD)
antibodies represents a useful tool to estimate the individual protection against Severe …

Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine

BL Sasso, RV Giglio, M Vidali, C Scazzone… - …, 2021 - search.proquest.com
Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD)
antibodies represents a useful tool to estimate the individual protection against Severe …